Skip to content

Author

Qiannan Cao

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

An inherent T cell-activating mRNA delivery carrier for in vivo CAR T generation.

An inherent T cell-activating polymer-lipid nanoparticle that enables ligand-free, efficient mRNA transfection and activation of T cells in vivo, and provides a clinically translatable approach for in vivo CAR T cell generation.

Qiannan Cao, Yingli Yao, Wenming Zheng et al. · 3 citations
Review Jul 2026

Non-viral and non-lipid nanoparticles for RNA therapeutics: Design, applications, and preclinical studies.

This review examines non-viral and non-lipid RNA nanocarriers from mechanistic and translational perspectives and highlights non-viral and non-lipid nanocarriers as complementary platforms for context-specific RNA therapy.

Mingxia Jiang, Qiannan Cao, Huapan Fang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.